FI973280A0 - Farmaseuttinen koostumus - Google Patents

Farmaseuttinen koostumus

Info

Publication number
FI973280A0
FI973280A0 FI973280A FI973280A FI973280A0 FI 973280 A0 FI973280 A0 FI 973280A0 FI 973280 A FI973280 A FI 973280A FI 973280 A FI973280 A FI 973280A FI 973280 A0 FI973280 A0 FI 973280A0
Authority
FI
Finland
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
FI973280A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI973280A (fi
Inventor
Andrea Lodi
Maria Teresa Rossato
Original Assignee
Glaxo Wellcome Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Spa filed Critical Glaxo Wellcome Spa
Publication of FI973280A publication Critical patent/FI973280A/fi
Publication of FI973280A0 publication Critical patent/FI973280A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI973280A 1995-02-11 1997-08-08 Farmaseuttinen koostumus FI973280A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9502695.1A GB9502695D0 (en) 1995-02-11 1995-02-11 Pharmaceutical composition
PCT/EP1996/000515 WO1996024376A1 (en) 1995-02-11 1996-02-08 Pharmaceutical composition for parenteral application containing an indole-carboxylic acid

Publications (2)

Publication Number Publication Date
FI973280A FI973280A (fi) 1997-08-08
FI973280A0 true FI973280A0 (fi) 1997-08-08

Family

ID=10769456

Family Applications (1)

Application Number Title Priority Date Filing Date
FI973280A FI973280A0 (fi) 1995-02-11 1997-08-08 Farmaseuttinen koostumus

Country Status (18)

Country Link
US (2) US5886018A (xx)
EP (1) EP0809514A1 (xx)
JP (1) JPH10513464A (xx)
KR (1) KR19980702109A (xx)
AU (1) AU707220B2 (xx)
BR (1) BR9607433A (xx)
CA (1) CA2212041A1 (xx)
CZ (1) CZ252897A3 (xx)
EA (1) EA000211B1 (xx)
FI (1) FI973280A0 (xx)
GB (1) GB9502695D0 (xx)
HU (1) HUP9702448A2 (xx)
IL (1) IL117098A0 (xx)
NO (1) NO973656L (xx)
NZ (1) NZ300937A (xx)
PL (1) PL321734A1 (xx)
WO (1) WO1996024376A1 (xx)
ZA (1) ZA961051B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9502695D0 (en) * 1995-02-11 1995-03-29 Glaxo Spa Pharmaceutical composition
US20030162825A1 (en) * 2001-11-09 2003-08-28 Sepracor Inc. D-amino acid oxidase inhibitors for learning and memory
US20040019075A1 (en) * 2002-05-29 2004-01-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg New formulation for the parenteral application of crobenetine
US7488747B2 (en) 2003-12-29 2009-02-10 Sepracor Inc. Pyrrole and pyrazole DAAO inhibitors
UA93365C2 (ru) 2005-02-01 2011-02-10 Троикаа Фармасьютикалс Лтд Инъекционная форма диклофенака и его фармацевтически приемлемых солей (варианты) и способ его приготовления (варианты)
US7579370B2 (en) * 2006-06-30 2009-08-25 Sepracor Inc. Fused heterocycles
US7884124B2 (en) * 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
US9737531B2 (en) 2012-07-12 2017-08-22 Glytech, Llc Composition and method for treatment of depression and psychosis in humans
CN110996948A (zh) 2017-06-12 2020-04-10 格莱泰施有限责任公司 用nmda拮抗剂和d2/5ht2a或选择性5ht2a拮抗剂治疗抑郁症

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT93943A (pt) * 1989-05-05 1991-02-08 Searle & Co Processo para a preparacao de composicoes contendo compostos indole-2-carboxilato para tratamento de perturbacoes do snc
DK0539503T3 (da) * 1990-07-16 1996-05-13 Merrell Pharma Inc Excitatoriske aminosyreantagonister
GB9208492D0 (en) * 1992-04-16 1992-06-03 Glaxo Spa Heterocyclic compounds
GB9502695D0 (en) * 1995-02-11 1995-03-29 Glaxo Spa Pharmaceutical composition

Also Published As

Publication number Publication date
KR19980702109A (ko) 1998-07-15
FI973280A (fi) 1997-08-08
MX9706044A (es) 1998-06-28
PL321734A1 (en) 1997-12-22
EP0809514A1 (en) 1997-12-03
EA199700095A1 (ru) 1998-02-26
BR9607433A (pt) 1998-05-26
CA2212041A1 (en) 1996-08-15
HUP9702448A2 (hu) 1999-10-28
WO1996024376A1 (en) 1996-08-15
NO973656L (no) 1997-10-08
GB9502695D0 (en) 1995-03-29
JPH10513464A (ja) 1998-12-22
AU4622896A (en) 1996-08-27
NZ300937A (en) 1999-02-25
NO973656D0 (no) 1997-08-08
IL117098A0 (en) 1996-06-18
CZ252897A3 (cs) 1998-03-18
AU707220B2 (en) 1999-07-08
US5886018A (en) 1999-03-23
ZA961051B (en) 1996-09-11
US6020359A (en) 2000-02-01
EA000211B1 (ru) 1998-12-24

Similar Documents

Publication Publication Date Title
NO20021172L (no) Farmasöytisk sammensetning
IS4706A (is) Lyfjasamsetningar
CY2005007I2 (el) Φαρμακευτικες συνθεσεις που περιεχουν δαριφενακινη
FI944832A0 (fi) Farmaseuttinen koostumus
BR9610396A (pt) Formulação farmacêutica
BR9607058A (pt) Composição
BR9606809A (pt) Composição inseticidamente ativa
BR9610214A (pt) Compostos farmacéuticos
ITMI932540A0 (it) Composizione farmaceutica
LV11727A (lv) Farmaceitiska kompozicija
DE69614407T2 (de) Pharmazeutische zusammensetzungen
FI973229A (fi) Uusi farmaseuttinen koostumus
BR9507768A (pt) Composição farmacêutica
ID18698A (id) Komposisi farmasi
FI973280A (fi) Farmaseuttinen koostumus
ITMI942166A0 (it) Composizioni farmaceutiche miorilassanti
FI973230A (fi) Uusi farmaseuttinen formulaatio
LV10579A (lv) Farmaceitiska kompozicija
BR9607946A (pt) Composição
BR9605777A (pt) Composição farmacêutica
NO965448L (no) Farmasöytiske forbindelser
ITMI962628A0 (it) Composizione farmaceutica
FI962738A0 (fi) Farmaseuttiset koostumukset
NO964309D0 (no) Farmasöytisk sammensetning
IT1272935B (it) Composizione farmaceutica contenente n-acetil-cisteina